Tenofovir Alafenamide News
Tenofovir Alafenamide currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Tenofovir Alafenamide with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (HIV 1) without known mutations associated with resistance...
- Evidence level: L5
- Predicted indications (20):
- HIV infectious disease (99.9%)
- simian immunodeficiency virus infection (99.9%)
- feline acquired immunodeficiency syndrome (99.9%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.9%)
- chronic hepatitis C virus infection (98.6%)
- AIDS (98.5%)
- obsolete familial combined hyperlipidemia (97.8%)
- AIDS related complex (97.1%)
- congenital human immunodeficiency virus (97.1%)
- hepatitis B virus infection (96.1%)
- hepatitis C virus infection (96.1%)
- hepatitis E virus infection (95.0%)
- hepatitis A virus infection (94.8%)
- Omsk hemorrhagic fever (94.8%)
- hepatitis, viral, animal (94.7%)
- Kyasanur forest disease (94.6%)
- fibroma of prostate (92.1%)
- Brenner tumor (92.0%)
- benign reproductive system neoplasm (91.9%)
- benign prostate phyllodes tumor (91.2%)
Related News (2)
Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau - The Guardian
2026-10-09 hepatitis
Source: The Guardian
Meteo estremo, cibo contaminato, ricoveri lunghi. A Roma è boom di Epatite A: perché c’è da preoccuparsi
2026-10-08 epatite
Source: RomaToday
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.